A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectants. by Fragaki, Konstantina et al.
A novel Leishmania infantum nuclear phosphoprotein
Lepp12 which stimulates IL1-beta synthesis in THP-1
transfectants.
Konstantina Fragaki, Bernard Ferrua, Baharia Mograbi, Julie Waldispu¨hl,
Joanna Kubar
To cite this version:
Konstantina Fragaki, Bernard Ferrua, Baharia Mograbi, Julie Waldispu¨hl, Joanna Kubar. A
novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis
in THP-1 transfectants.. BMC Microbiology, BioMed Central, 2003, 3, pp.7. <10.1186/1471-
2180-3-7>. <inserm-00115583>
HAL Id: inserm-00115583
http://www.hal.inserm.fr/inserm-00115583
Submitted on 6 Dec 2006
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

BioMed Central
Page 1 of 13
(page number not for citation purposes)
BMC Microbiology
Open AccessResearch article
A novel Leishmania infantum nuclear phosphoprotein Lepp12 which 
stimulates IL1-beta synthesis in THP-1 transfectants
Konstantina Fragaki1,4, Bernard Ferrua1, Baharia Mograbi2, 
Julie Waldispühl1,5 and Joanna Kubar*1,3
Address: 1Groupe de Recherche en Immunopathologie de la Leishmaniose (EA 2675), Faculté de Médecine, Nice, France, 2Inserm EMI 00-092, 
Faculté de Médecine, Nice, France, 3Laboratoire de Parasitologie, Hôpital de l'Archet de Centre Hospitalier Universitaire (CHU), Nice, France, 
4present address: Agence Française de Sécurité Sanitaire des Aliments (AFSSA), Nancy, BP 9, 54220 Malzeville, France and 5present address: Institut 
für Immunologie, Ludwig-Maximilians-Universität München, Munich, Germany
Email: Konstantina Fragaki - k.fragaki@afssa.fr; Bernard Ferrua - ferrua@unice.fr; Baharia Mograbi - mograbi@unice.fr; 
Julie Waldispühl - jwaldispuhl@yahoo.fr; Joanna Kubar* - kubar@unice.fr
* Corresponding author    
Abstract
Background: We report cloning and characterization of a novel Leishmania infantum protein
which we termed Lepp12, and we examine its possible implication in the interference with
intramacrophage signaling pathways.
Results: The protein Lepp12 contains 87 amino acid sequence and exhibits 5 potential
phosphorylation sites by protein kinase C (PKC). Recombinant GST-Lepp12 is phosphorylated in
vitro by exogenous PKC and by PKC-like activities present in promastigote and in the
myelomonocytic THP-1 cell line, indicating that at least one phosphorylation site is functional on
the recombinant Lepp12. The natural Lepp12 protein is present in L. infantum promastigotes, as
evidenced using specific anti-Lepp12 antibodies produced by immunopurification from acute phase
VL patient sera. Interestingly, human patient sera are strongly reactive with GST-Lepp12,
demonstrating immunogenic properties of Lepp12 in man, but no immune response to Lepp12 is
detectable in experimentally infected animals. When isolated from promastigotes, Lepp12 migrates
as two species of apparent MW of 18.3 kDa (major) and 14 kDa (minor), localizes in the nuclear
fraction and appears constitutively phosphorylated. Natural Lepp12 is phosphorylable in vitro by
both exogenous PKC and PKC-like activity present in THP-1 extracts. The intracellular Lepp12
transfected into THP-1 cells activates these cells to produce IL-1beta and induces an enhancing
effect on PMA stimulated IL-1beta synthesis, as demonstrated using GST-Lepp12 transfectants.
Conclusions: Together these results indicate that Lepp12 represents a substrate for PKC or
other PKC-like activities present in the promastigote form and the host cell and therefore may
interfere with signal transduction pathways involving PKC.
Background
Leishmaniases are parasitic diseases due to protozoa of
the genus Leishmania transmitted by sandflies of the genus
Phlebotomus. In the vertebrate host,Leishmania live in mac-
rophages as obligate intracellular amastigotes, and as flag-
ellated free promastigotes in the intestine of the sandfly
vector. There are at least 20 different species of Leishmania
parasites causing a wide spectrum of human diseases,
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ranging in severity from spontaneously healing skin le-
sions to fatal visceral leishmaniasis [1,2]. The prevalence
of the disease worldwide is estimated to be 12 million cas-
es and an incidence of 500 000 new cases of visceral and
1 500 000 of cutaneous disease has been reported [1]. Pat-
ent visceral leishmaniasis (VL) caused by L. infantum (L.
chagasi) is a fatal infection when left untreated [2]. There
is an increasing incidence of the disease in HIV-infected
individuals in southern Europe, [3,4] and post-therapeu-
tically, in organ transplantation [5]. This is due, in part, to
the reactivation of latent Leishmania in persons presenting
immunosuppressed conditions [4]. Indeed, in endemic
regions the existence of asymptomatic Leishmania carriers
has been documented [6,7] and in successfully treated VL
patients the currently available drugs do not result in the
complete elimination of the parasite.
Leishmania parasites developed various strategies to over-
come the protection provided by the immune system of
the host [for review [8,9]]. In particular, phosphorylation
reactions have been shown to participate in several ways
in escape mechanisms, at different levels of the parasite-
host interaction. For instance, a protein kinase isolated
from L. major (LPK-1) is able to phosphorylate compo-
nents of the human complement system (C3, C5 and C9)
leading to its inactivation [10]. Intracellular Leishmania
amastigotes, not only adapt to phagolysosomal low pH
(5.5) and high temperature (37°C) in order to survive in
the host cells [11,12], but also induce functional modifi-
cations in macrophages. These include decrease in cy-
tokine production, inhibition of oxydative burst activity,
alteration of antigen presentation, and of expression of
MHC class II molecules. This ability of Leishmania to in-
hibit macrophage effector activities, also termed deactiva-
tion [8,13], may result from a direct interference of
leishmanial molecules with macrophage signal transduc-
tion pathways. In particular, inhibition of macrophage
protein kinases such as protein kinase C (PKC) [14–16]
and Janus kinases [17,18], as well as alteration of stimu-
lus-induced intracellular calcium gradient and decreased
production of inositol 1, 4, 5-triphosphate [19,20] have
been reported. The inhibition of PKC-depending signal-
ing by Leishmania is well documented, and the effect can
be ascribed in part to the properties of lipophosphoglycan
(LPG) [21–28].
In this paper we report cloning and characterization of a
novel L. infantum protein termed Lepp12, the predicted
aminoacid sequence of which contains 5 potential sites of
phosphorylation by PKC and examine its possible impli-
cation in the interference of intramacrophage signaling
pathways.
Results
Cloning of a novel L. infantum cDNA and production of 
recombinant protein GST-Lepp12
After screening two expression L. infantum cDNA libraries
with an acute-phase VL patient serum a 214-bp lambda
gt11 insert was selected and sequenced of as described
previously [29]. Then, the 267-bp ORF of Lepp12 was ob-
tained using RACE-PCR on retrotranscribed promastigote
mRNA, as indicated in the Methods section [29]. Figure 1
shows the deduced 87 amino acid sequence of predicted
molecular weight of 11.6 kDa. Its analysis exhibits 5 po-
tential phosphorylation sites (bold characters) and one N-
glycosylation site (underlined). No homologies of
Lepp12 with sequences of Leishmania proteins reported to
date were found. The recombinant GST-Lepp12 protein
migrates, as expected, at 38.5 kDa (Figure 2, lane 1). It was
produced in parallel with GST (Figure 2, lane 2), as a con-
trol. The very faint band at 34 kDa could correspond to a
proteolytic degradation of the fusion protein during its
production by E. coli bacteria, according to a recently pub-
lished study [30]. A yield of approximately 30 microg of
GST-Lepp12 per 100 ml culture was determined after elec-
trophoresis gel staining.
Identification and localization of the natural Lepp12 in L. 
infantum
In order to evidence a corresponding natural Lepp12 in L.
infantum promastigotes, specific anti-Lepp12 antibodies
were first isolated. Interestingly, no immune response to
Lepp12 was detected in experimentally infected animals
(107 stationary promastigotes per animal by iv and ip
route for mice and hamsters, respectively; not shown),
while immunization of hamsters with GST-Lepp12 result-
ed in sera presenting a quite low titer of anti-Lepp12 anti-
bodies (not shown). Conversely, as shown on Figure 3
sera collected from patients at VL diagnosis are strongly re-
active with the fusion protein GST-Lepp12, demonstrat-
ing immunogenic properties of Lepp12 in man. Of note,
Figure 1
Predicted amino acid sequence of Lepp12. Motives corre-
sponding to potential phosphorylation sites (bold), and 
potential N-glycosylation site (underlined) are given by the 
consensus sequences found by the BLAST search method. 
cDNA sequence is available under the accession number 
AF540954 in GenBank.
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sera from LST positive asymptomatic subjects were not
reactive (not shown). Therefore to obtain the specific anti-
Lepp12 IgG we performed immunopurification of sera
from patients presenting strong anti-GST-Lepp12 respons-
es, as described in the Methods section.
The natural Lepp12 protein in L. infantum promastigotes
was then identified by western blotting. It migrates as one
intense immunoreactive band at 18.3 kDa and one weak-
er band at 14 kDa, (Fig. 4 lane 4). The reactivity of the
used immunopurified antibody on the recombinant GST-
Lepp12 and on GST and GST-papLe22 [29] are shown as
positive (lane 1) and negative (Fig. 4, lanes 2 and 3) con-
trols, respectively. At first sight it might appear surprising
that, as evidenced in Fig. 4, 5 microg of recombinant pro-
tein Lepp12 are recognized with almost the same intensity
as the natural Lepp12 protein contained in 15 microg of
the promastigote lysate. But one has to remember that the
source of antibodies used in these experiments were hu-
man patients sera and therefore the antibodies, although
affinity purified on rLepp12, are originally directed
against the natural Lepp12. The expression of Lepp12
cDNA in L. infantum promastigotes and amastigotes was
demonstrated by RT-PCR (not shown). In order to deter-
mine the natural Lepp12 localization in cellular compart-
ments, western blotting was carried out after promastigote
fractioning, using immunopurified anti-Lepp12 antibod-
ies. Figure 5 reveals the same two immunoreactive bands,
the intense at 18.3 kDa and the weak at 14 kDa in the total
unfractionated promastigote SDS lysate (Fig. 5 lane 1),
and in the nuclear extract (Fig. 5 lanes 5 and 6), and no
detectable material in the remaining cell fractions. These
Figure 2
Purification of recombinant proteins. The recombinant pro-
teins GST-Lepp12 (rLepp12, 38.5 kDa, lane 1) and GST (29 
kDa, lane 2) were purified from E. coli BL21 induced cultures 
(0.1 mM IPTG for 2 h). Bacteria were extracted with 1% Tri-
ton X-100 and fusion proteins were purified on gluthatione 
sepharose column. Five microg of eluted material was ana-
lyzed by SDS-PAGE (14% polyacrylamide) and Coomassie 
Blue staining. Molecular mass markers are indicated in kDa.
Figure 3
Anti-Lepp12 antibody responses in patients with clinically and 
parasitologically diagnosed VL. Reactivities of diagnosis and 
follow up sera against recombinant Lepp12 from eight VL 
patients are shown. GST-Lepp12 and GST, purified as 
described in Methods section, were eluted from gluthatione 
sepharose with 0.1% SDS in PBS. Recombinant proteins were 
coated at 0.05 microg per well onto microtiter plate and 
sequentially incubated with patient serum diluted 1:100 and 
peroxidase-labeled anti-human IgG. Absorbencies obtained 
with GST-Lepp12 were corrected for absorbencies meas-
ured with GST alone. Sera from leishmanin skin test (LST) 
negative controls gave OD values below 0.1. The patient's 
serum with the highest titer at diagnosis was selected for the 
preparation of the immunopurified anti-Lepp12 antibodies. 
Typically 20 microg of immunopurified anti-Lepp12 antibody 
were obtained from 1 ml of serum.
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results indicate that natural protein Lepp12 is located in
promastigote nucleus. The presence in the Lepp12 amino
acid sequence of a motif associating a proline with 3 basic
amino acids (Figure 1, RPKR, aa 19 to 22), might be indic-
ative of the nuclear location of the protein.
In vitro phosphorylation of recombinant Lepp12
Several in vitro assays were carried out in order to examine
the capacity of Lepp12 to get phosphorylated. In a first se-
ries of experiments the recombinant protein was incubat-
ed with purified exogenous protein kinase C (PKC).
Figure 6 shows a phosphorylated band migrating, at the
MW of 38.5 kDa (lane 4) corresponding to GST-Lepp12.
Preparations of the GST protein (lane 6), of a lysate of not
transformed E. coli (lane 5), both produced in parallel
with GST-Lepp12, and reaction mix alone (lane 2) were
also incubated with PKC to provide negative controls. A
histone mix was used as a positive control of phosphor-
ylation reaction (lane 1). This result indicates that among
the potential phosphorylation sites of Lepp12, al least one
site is functional and that recombinant Lepp12 is a sub-
strate of PKC in vitro. Next, the promastigote lysate, added
to the recombinant Lepp12, was used as a possible source
of enzymatic activity in an in vitro assay. Figure 7 shows
that, indeed, a kinase activity able to phosphorylate GST-
Lepp12 (lane 7), and also the histone mix (lane 3), is
present in promastigotes. In this experiment, phosphor-
ylation of the fusion protein GST-Lepp12 by the exoge-
nous PKC was used as positive control (lane 5). The
enzymatic activity present in promastigote lysate was in-
hibitable by kinase inhibitor bisindolylmaleimide VIII
(data not shown) when it was used at the concentration of
1 microM, suggesting its PKC-like character.
Phosphorylation of natural Lepp12 protein
First, we checked that natural Lepp12 was phosphorylated
by exogenous PKC in an in vitro phosphorylation assay
(not shown). Then, in order to find out what is the phos-
phorylation status of the natural Lepp12 in promastig-
otes, the protein was first immunoprecipitated from the
nuclear extract using specific immunopurified anti-
Figure 4
Identification of natural Lepp12 (nLepp12) in promastigotes. 
Five micrograms of GST-Lepp12 (rLepp12, lane 1) used as 
positive control, or GST (lane 2) or GST-papLe22 (rpapLe22, 
lane 3) used as negative controls, or 15 microg of leishmanial 
proteins (total promastigote lysate in SDS 3%, lane 4) were 
electrophorezed and electrotransfered onto nitrocellulose. 
Western blotting was performed with anti-Lepp12 antibodies 
(at 2 microg/ml) immunopurified on Lepp12-coated latex 
beads from an acute phase VL patient serum, which was pre-
viously absorbed with 0.5 ml of E. coli lysate. Molecular mass 
markers are indicated in kDa.
Figure 5
Natural Lepp12 protein is non-secreted protein located in 
promastigote nucleus. Western blotting was performed using 
immunopurified anti-Lepp12 antibodies (at 2 microg/ml) on 
total promastigote 3 % SDS lysate (positive control, lane 1), 
20 % NP40 lysate (lane 2), cytosol (s1, lane 3), cell mem-
branes (c1, lane 4), nuclear extract prepared as described in 
Methods section before (lane 5) or after (lane 6) 3% SDS 
lysis, and PEG concentrated culture supernatant (lane 7). 
Proteins were prepared from 1.6 × 108 cells. In each lane, 30 
microg of proteins were separated on a 14% polyacrylamide 
SDS-gel, corresponding to an equivalent of 4 millions (lane 1), 
8.6 millions (lane 2), 5.3 millions (lane 3), 4.8 millions (lane 4), 
18.5 millions (lane 5), 12 millions (lane 6) and 2.2 millions 
(lane 7) promastigotes. Molecular mass markers are indicated 
in kDa.
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Lepp12 antibodies as described above, and western blot
analysis was next carried out using a mix of anti-phospho-
serine and anti-phosphothreonine antibodies. Figure 8
shows that the natural Lepp12 immunoprecipitated from
the nuclear extract was revealed by anti-P-Ser/P-Thr anti-
body, indicating that it is present in the promastigote nu-
cleus in a phosphorylated state (lane 1). A mock
immunoprecipitation using IgG irrelevant to Lepp 12 was
used as negative control (lane 3). Interestingly, in the total
promastigote lysate (lane 2), the antibodies revealed an
impressive variety of proteins of molecular weight ranging
Figure 6
Recombinant protein Lepp12 is phosphorylated by purified 
exogenous PKC (ePKC) in the presence of 10 microCi 
gamma-P32 ATP in an in vitro assay. rLepp12: GST-Lepp12; h: 
histone mix as positive phosphorylation reaction control; 
GST; rb: reaction buffer; cl: E. coli lysate, as negative controls. 
Autoradiogram is shown after exposition time of 30 min.
Figure 7
Recombinant protein Lepp12 is phosphorylated by an enzy-
matic activity present in promastigote lysate (proML), in the 
presence of 10 microCi gamma-P32 ATP in an in vitro assay. 
rLepp12: GST-Lepp12; h: histone mix as positive phosphor-
ylation reaction control; GST; rb: reaction buffer; cl: E. coli 
lysate, as negative controls. n = no enzymatic activity added. 
Autoradiogram is shown after exposition time of 24 hours.
Figure 8
Natural Lepp12 is present in promastigote nucleus as a phos-
phoprotein. Mixture of anti-phosphoserine and anti-phos-
phothreonine antibodies was used in the western blotting 
shown in order to evidence phosphoproteins. Enzymatic 
activity of anti-rabbit IgG peroxidase conjugate was revealed 
by chemiluminescence. Natural Lepp12 (nLepp12, lane 1) 
was immunoprecipitated from the promastigote nuclear 
extracts (corresponding to 3 × 109 cells) using anti-Lepp12 
IgG (25 microg at 100 microg/ml). The immunoprecipitated 
material was Lepp12-specific as testified by control immuno-
precipitation (cAb) performed with irrelevant IgG (lane 3). 
15 microg of total promastigote lysate (proM, lane 2) was 
electrophorezed and electrotransfered onto nitrocellulose in 
parallel. Exposition time of MP-hyperfilm was 10 sec.
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between 14 kDa and 45 kDa which are phosphorylated in
the cell on serine and/or threonine residues.
Phosphorylation of the recombinant and the natural 
Lepp12 by lysate of THP-1 cells
The THP-1 myelomonocytic human cell line was used
here since it provides a model of macrophages, the natural
Leishmania host cells. We first examined the possibility of
existence in these cells of kinase activity(ies) able to phos-
phorylate the recombinant and natural Lepp12. Figures 9
and 10 show that in both series of experiments, lysates
prepared from THP-1 cell line were able to phosphorylate
in vitro recombinant GST-Lepp12 (Fig. 9, lane 7) and nat-
ural immunoprecipitated Lepp12 (Fig. 10, lane 5), indi-
cating the presence in this cell line of kinase(s) active on
this leishmanial protein. The appropriate positive (Fig. 9,
lanes 3, 5; Fig. 10, lane 6) and negative controls (Fig. 9,
lanes 1, 2, 4, 6; Fig. 10, lanes 1–4) are described in the Fig-
ure legends.
Figure 9
Enzymatic activity present in THP-1 cells phosphorylates 
recombinant protein Lepp12, in the presence of 10 microCi 
gamma-P32 ATP in an in vitro assay. E. coli lysate (cl, lane 1), 
reaction buffer (rb, lane 2) and GST (lane 4) were used as 
negative substrate controls. Phosphorylation of histone mix 
(h, lane 3) by THP-1 lysate (THP-1L) and of GST-Lepp12 
(rLepp12) by exogenous PKC (ePKC, lane 5) were per-
formed as positive controls. n = no enzymatic activity added. 
Autoradiogram is shown after exposition time of 24 h.
Figure 10
Enzymatic activity present in THP-1 cells phosphorylates nat-
ural protein Lepp12, in the presence of 10 microCi gamma-
P32 ATP in an in vitro assay. THP-1 lysate (THP-1L) was used 
as source of enzymatic activity. Natural Lepp12 (nLepp12, 
lanes 4, 5) was immunoprecipitated from the promastigote 
nuclear extracts (corresponding to 3 × 109 cells) using anti-
Lepp12 IgG as described in FIG. 8. Control immunoprecipita-
tion (cAb) was performed with irrelevant IgG (cAb, lanes 2, 
3). Histone mix is also phosphorylated by an enzymatic activ-
ity present in THP-1 cells (h, lane 6). In this experiment, a 
phosphorylated monomeric form in the histone mix was 
detected, in contrast to the experiment depicted in fig. 9. 
Autoradiogram is shown after exposition time of 24 h.
Figure 11
GST-Lepp12 and GST protein preparations used for trans-
fection experiments (see FIGS. 12 and 13) are devoid of 
measurable endotoxin-like activity, as measured by IL-1beta 
synthesis by wild-type THP-1 cells. IL-1beta measured by 
sandwich ELISA in CHAPS lysate of THP-1 cells after 24 h 
culture of the cells (5 × 104 cells per 200 microL) in the pres-
ence of GST-Lepp12 (closed diamonds) or GST (closed 
squares) was under the sensitivity threshold of the ELISA (10 
pg/ml). LPS-induced IL-1beta (open squares) is shown as a 
positive control. It was above 4 ng/ml when LPS was used at 
concentrations over 10 ng/ml.
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Effect of Lepp12 on IL-1beta production by THP-1 cells
In order to investigate the influence of intracellular
Lepp12 on macrophage activation and particularly on cy-
tokine production by THP-1 cells, we generated cells
transfected with the GST-Lepp12 and with GST using
Chariot Transfection Kit. Prior to all the transfection
experiments, all preparations of recombinant proteins
were tested for the presence of bacterial contaminants, by
measure of IL-1beta production by THP-1 cells cultured
for 24 h in the presence of various dilutions of these prep-
arations. Fig 11 shows that GST-Lepp12 and GST prepara-
tions were unable to induce detectable levels of IL-1beta
from untransfected THP-1 cells. This lack of effect was ob-
served even at protein concentrations above those selected
in transfection experiments. This result indicates that both
preparations were devoid of endotoxin-like activity as as-
sessed by induction of IL-1beta synthesis, and therefore
rules out an involvement of such an activity in the effects
observed in GST or GST-Lepp12 transfected THP-1 cells.
In the next series of experiments, the synthesis of IL-1beta
was assayed in the THP-1 cells transfected with GST-
Lepp12 or with GST, or untransfected, incubated in the
absence and the presence of LPS (Fig. 12) or PMA (Fig.
13). The data show that IL-1beta basal production was
undetectable in untransfected and GST-transfected cells
whereas low but significant amounts (80–120 pg/ml)
were reproducibly assayed from GST-Lepp12 transfected
cells (Fig. 12 and 13). The LPS-induced IL-1beta levels
were not significantly different in all cell types, whatever
the effector concentrations. In contrast, the PMA stimulat-
ed monokine levels were higher in GST-Lepp12 transfect-
ed cells. The enhancing effect of Lepp12 on PMA-induced
IL-1beta was more pronounced at low PMA concentra-
tions (10-fold at 0.1 ng/ml versus 3.5-fold at 10 ng/ml).
Taken together these results suggest that intracellular
Lepp12 by itself or in synergy with PMA is specifically able
to activate THP-1 cells to produce the pro-inflammatory
cytokine IL-1beta.
Discussion
In this paper we report the cloning and characterization of
a novel L. infantum protein termed Lepp12. The 267
nucleotide long ORF was identified by screening a L. in-
fantum cDNA library with an acute phase VL patient se-
rum. The deduced 87 aminoacid sequence corresponds to
a 11.6 kDa hydrophile, positively charged, protein with
no homology with L. infantum protein sequences reported
to date. Interestingly, Lepp12 exhibits 5 potential phos-
phorylation sites for protein kinase (PKC) and one N-gly-
cosylation site. The fusion protein produced in E. coli and
purified by glutathione-sepharose affinity
chromatography showed by SDS-PAGE analysis one ma-
jor band at the expected M.W. (38.5 kDa) and at least one
smaller M.W. component at 34 kDa. As previously report-
ed [30], partial proteolysis occurring during production in
E. coli is likely to account for this phenomenon.
The purified fusion protein was used as capture antigen
for evaluating the anti-Lepp12 antibody response in
human with VL as well as in experimentally infected
mouse and hamster. All patients tested were treated, fol-
lowing the clinical and parasitological diagnosis. Patients
with obvious VL but not LST positive asymptomatic indi-
viduals showed at diagnosis anti-Lepp12 reactivity by
ELISA or Western blotting (WB) which gradually declined
following successful therapy resulting in clinical cure. Of
note, VL patients serum samples recognized the low MW
fusion protein compound in WB analysis thus supporting
the Lepp12-like nature of this component. Conversely,
anti-Lepp12 antibodies were undetectable by ELISA in ex-
perimentally infected mouse or hamster and attempts to
prepare anti-Lepp12 antiserum in these animals by
immunization with DNA encoding Lepp12 protein or pu-
rified GST-Lepp12 were either unsuccessful or resulted in
Figure 13
Intracellular Lepp12 activates THP-1 cells to produce IL-
1beta and induces an enhancing effect on PMA-stimulated IL-
1beta synthesis. IL-1beta was measured as described in FIG. 
11 from THP-1 cells (7.5 × 104 cells per 200 microL), 
untransfected (dotted bars) or GST-transfected (open bars) 
or GST-Lepp12-transfected (hatched bars), cultured in the 
absence or in the presence of PMA at indicated concentra-
tions (in ng/ml). GST-Lepp12 protein and GST protein were 
transfected into the THP-1 cells using Chariot Transfection 
Kit as described in Methods section. One representative 
experiment out of three performed is shown
BMC Microbiology 2003, 3 http://www.biomedcentral.com/1471-2180/3/7
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low titers immune sera, respectively. Consequently, im-
munopurified human anti-Lepp12, obtained by passage
of E. coli-absorbed VL patient serum sample unto GST-
Lepp12-coated latex column, were used as source of anti-
Lepp12 antibody for the following experiments. This anti-
body preparation was shown to specifically detect by WB
analysis the 38.5 kDa fusion protein as well as the low
MW compound and was used to detect natural Lepp12 in
crude promastigote preparation and in nuclear extract.
The species-specific humoral reactivity to Lepp12 deserves
a comment. The fact that in infection of species other than
human, the anti-Lepp12 antibody response was
undetectable, while in human VL patients the response
was detectable only at low serum dilutions, indicates that
Lepp12 behaves as a weak immunogen, in contrast to
papLe22. Moreover, the lack of a notable antibody re-
sponse following extensive immunization of hamster,
suggests existence of anti-Lepp12-repertoire or Lepp12-
processing/presentation deficiencies in this and other an-
imal laboratory species. Taken together, if one considers
that Lepp12 is a weak immunogen, it is not surprising that
only the most potent immune system can mount a
detectable antibody response. Indeed, high responder
character of human immune system to Leishmania pro-
teins has been already emphasized, since anti-promastig-
ote antibody responses measured in patients with VL
exceeded by far those obtained with experimentally infect-
ed mouse or hamster or naturally infected dogs [31].
Natural endogenous Lepp12 appeared under two molecu-
lar entities migrating with apparent MW of 18.3 kDa and
14 kDa, the former being more represented. This discrep-
ancy with the expected MW derived from the amino acid
analysis can be explained by the occurrence in the
promastigote Lepp12 of different glycosylation and/or
phosphorylation states, the latter being known to modify
the electrophoretic mobility of proteins [32].
Nevertheless, as reported earlier [33], the occurrence in
promastigote fraction of two cross reactive entities with
different MW cannot be totally excluded. In addition,
there are three features indicating that tLepp12 could be-
long to the p14 and p18 nuclear fractions that we have
previously reported [33]. First, the anti-Lepp12 antibodies
recognize two bands of similar molecular weight to p14
and p18 fractions, second, p14 and p18 antigens share
common epitopes and.third, Lepp12, p14 and p18 are all
nuclear proteins. Finally, using RT-PCR Lepp12 mRNA
was also detectable in amastigote, thus indicating that
Lepp12 is likely to be present during parasite replication
in host cell.
Amino acid sequence analysis of Lepp12 demonstrated 5
potential phosphorylation sites for PKC. In order to verify
the functionality of these sites, several in vitro phosphor-
ylation experiments were performed using as target either
the fusion protein or immunocaptured natural Lepp12.
GST-Lepp12 was phosphorylated in vitro by exogenous
PKC and by PKC-like activities present in promastigote
and in the myelomonocytic THP-1 cell line. These results
indicate that at least one functional phosphorylation site
is present on the recombinant Lepp12. In the same way,
natural Lepp12, when immunoprecipitated, appeared to
be also phosphorylated by both exogenous PKC and PKC-
like activity present in THP-1 extracts. In promastigote,
natural Lepp12, which was shown to localize in the nucle-
ar fraction, appears under a constitutive phosphorylated
state. Although there is not yet a direct proof, such as the
natural protein sequencing or knock out experiments, of
the identity of the Lepp12 ORF isolated from the library
and the antigens recognized in the nuclear extracts, our
data, brought to light in a logical sequence, provide a
number of strongly converging indications for such iden-
tity. First, the recombinant Lepp12 (rLepp12) is phospho-
rylated in several in vitro assays. Second, a natural protein
Figure 12
Intracellular Lepp12 activates THP-1 cells to produce IL-
1beta and and has no effect on LPS-stimulated IL-1beta syn-
thesis. IL-1beta was measured as described in FIG. 11 from 
THP-1 cells (7.5 × 104 cells per 200 microL), untransfected 
(dotted bars) or GST-transfected (open bars) or GST-
Lepp12-transfected (hatched bars), cultured in the absence 
or in the presence of LPS at indicated concentration (in 
microg/ml). GST-Lepp12 protein and GST protein were 
transfected into the THP-1 cells using Chariot Transfection 
Kit as described in Methods section. One representative 
experiment out of three performed is shown.
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is recognized and localized in promastigote nuclear
extract using antibodies affinity purified on rLepp12.
Third, this natural protein is phosphorylated in the same
vitro assays. Finally, this natural protein immunoprecipi-
tated from promastigote nuclear extract is shown to be
constitutively phosphorylated. There is an as yet unan-
swered question, namely whether and how does Lepp12
reach the host cell cytoplasm. At the present stage of our
study we can hypothesize that Lepp12, being a protein
strongly charged by positive residues, is able to cross
membranes and to migrate in various compartments in a
manner analogous to that of the TAT protein of HIV [34].
An additional, not exclusive, possibility is that Lepp12
presence in the host cell cytoplasm results from parasite
destruction. A question, which seems related to this one,
and to which there is no as yet a clear answer, is by which
mechanisms the parasite nuclear proteins such as histones
or papLe22 elicit strong immune responses in the verte-
brate host. The concept of widely distributed antigens
called panantigens with prominent immunogenicity
addressed by Requena and collaborators [35] may answer
this question.
Together our results indicate that the natural Lepp12 rep-
resents a substrate for PKC or other PKC-like activities or
for phosphatase activities present in the promastigote and
the host cell and therefore may interfere with signal trans-
duction pathway involving PKC. This assumption was in
part supported by the data obtained using transfection ex-
periments. Indeed, unstimulated and PMA-stimulated
GST-Lepp-12-transfected THP-1 cells produced markedly
more IL-1beta than untransfected and GST-transfected
controls whereas LPS-induced cytokine remained in all
cases unchanged. These results indicate that in our in vitro
model, Lepp12 interferes specifically with IL-1beta
production dependent on PMA induced signaling path-
way. The relevance of these findings lays in the crucial role
played by IL-1beta as a main pro-inflammatory cytokine
and as a main co-stimulatory factor of primary T-cell acti-
vation [36].
Several questions arising about Lepp12-transfected THP-1
cells are of relevance in order to better understand the role
of Lepp12 in the host parasite interaction. First, does the
presence of Lepp12 result in an increased transcription of
the IL-1 gene and in this case, which are the IL-1
transcription factors that are modulated? Our observa-
tions showing that a Leishmania protein can be a putative
macrophage activator are reinforced by a recent report
[37] showing that L. major activates IL-1alpha gene tran-
scription in macrophage cell line. Next, at what level of
the signal transduction pathway is implicated the effect of
Lepp12? Whether Lepp12 interferes with PKC directly or
the downstream phosphorylation cascade leading to mac-
rophage activation remains to be determined. Alternative-
ly, Lepp12 under its phosphorylated form may inactivate
phosphatases thus enhancing protein kinase activities in-
volved in macrophage activation. These two hypotheses
are of prime importance in the context of the parasite/host
cell interaction. Indeed, invasion of macrophage by L. in-
fantum or other Leishmania spp. was repeatedly reported to
lead to a general deactivation of host cell with most genes
being down regulated. This macrophage impairment fol-
lowing parasite entry includes innate and cell-mediated
immune response such as phagocytosis [38], nitric oxide
generation [39] and IL-12 production [40] and results in
increased parasite survival inside the host cell [8,9]. A va-
riety of mechanisms potentially contributing to macro-
phage deactivation during intracellular infection have
been identified and among these, disruption of important
target cell functions through interference with signal
transduction is well documented. For example, infection
with L. donovani selectively attenuates the IFNgamma-ac-
tivated Jak-Stat1 pathway [17], reduces PMA-induced PKC
activity [19] and impairs PKC-induced c-fos expression
[41] or stimulates phosphotyrosine phosphatase SHP-1
[42]. On the contrary, L. donovani attachment was shown
to stimulate PKC-mediated oxidative events in bone-mar-
row derived macrophages [43] and glycosylphosphati-
dylinositol of L. mexicana were found to activate PKC and
protein tyrosine kinases in RAW 264 cells [44]. In this
context Lepp12 appears, at least in our in vitro model,
rather as a putative PKC enhancer. It also remains to be ex-
amined how our observations on the effect of Lepp12 on
THP-1 activability can be translated to more physiological
systems, in particular to Lepp12-transfected macrophag-
es? Does Lepp12 impairs macrophage functions such as
nitric oxide production? Finally, one should understand
how an activation of one gene [37] or even of a series of
genes by a protein can be integrated in the complex situa-
tion which occurs following parasite entry and which re-
sults in the global host cell deactivation. Indeed, it may be
possible that during infection which involves numerous
and complex amastigote antigens/host cell interactions,
Lepp12 behaves quite differently and participates to the
disruption of the protein kinase/protein phosphatase
homeostatis leading to macrophage impairment.
Methods
Cell cultures and cell preparations
The promastigote form of L. infantum MON-1 (MHOM/
FR/94/LPN101) was cultured in a complete RPMI medi-
um at 25°C under usual conditions [33], except in some
experiments indicated in the text where Fetal Calf Serum
(FCS) was substituted by 0.1 % BSA. Early stationary
phase promastigotes (5-day-old cultures) were used to
carry out various cell preparations, unless indicated other-
wise in figure legends, and were washed 3 times by sedi-
mentation at 206 g for 5 min at 4°C in PBS containing 1
mM NaVO4. For western blot analyses promastigotes were
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lysed in an electrophoresis buffer previously heated at
100°C for 10 min (100 mM Tris pH 6.8, 3 % SDS, 12.5 %
glycerol). Promastigote lysates used to stimulate phos-
phorylation of recombinant Lepp12 were obtained as su-
pernatants of centrifugation at 20,600 g for 15 min at 4°C
after lysis of PBS-washed cells for 30 min at 4°C in water
containing 1% NP40, 1 mM NaVO4, 25 mM beta-glycer-
ophosphate, 50 microM NaF, 2.5 mM NaPPi and 1 tablet
(per 1 ml) of complete protease-inhibitor-cocktail (Ro-
che, Meylan France). Nuclear extracts were prepared as
follows: washed promastigote pellet was incubated for 10
min on ice in 0.5 ml of lysis buffer 1 (Hepes 10 mM, pH
7.5, MgCl2 1.5 mM, KCl 10 mM, DTT 0.5 mM, NP40 0.5
%, supplemented with proteases and phosphatases inhib-
itors as above), centrifuged (1,460 g, 10 min, 4°C), and
the resulting pellet was incubated for 20 min on ice with
0.1 ml of lysis buffer 2 (Hepes 200 mM, pH 7.5, MgCl2 1.5
mM, KCl 840 mM, DTT 0.5 mM, glycerol 25%, EDTA 0.2
mM, supplemented with proteases ans phosphatases in-
hibitors). After centrifugation (15,500 g, 15 min, 4°C),
the resulting supernatant was recovered. For immunopre-
cipitation experiments 0.1 ml of nuclear extract was first
incubated with 23 microL of immunopurified anti-
Lepp12 antibodies (or control, irrelevant human antibod-
ies) for 5 h at 4°C under gentle agitation, then after add-
ing 20 microL settled volume of mixed (1:4, v/v) protein
A sepharose/sepharose 4B, incubation continued over-
night as before. After centrifugation (20,600 g, 2 min,
4°C), 100 microL of 4X electrophoresis buffer supple-
mented with 16% betaME was added to the resulting pel-
let or the pellet was used in phosphorylation experiments
(see below). The amastigote form used to prepare RNA
was purified from hamster spleen [45]. Human mono-
cytic cell line THP-1 was cultured in a complete RPMI me-
dium and cell lysates used to stimulate phosphorylation
of the recombinant and the natural Lepp12 were prepared
as described above. The protein content in all cell prepa-
rations was measured using the Micro BCA Protein Assay
Reagent kit, following supplier's (Pierce, Perbio, Bezons
France) recommendations.
Screening of cDNA libraries
Two libraries of L. infantum promastigote cDNA (synthe-
sized with oligodT primer or random hexaprimers) in
lambda-gt11 bacteriophage were kindly provided by Dr.
Carlos Alonso (Madrid). Approximately 105 lambda-gt11
plaques were screened for each library, using an acute-
phase patient serum as previously described [29].
PCR amplifications, cloning and sequencing
For cDNA synthesis, total RNA from 5.108 L. infantum
promastigotes and 5.107 L. infantum amastigotes was ex-
tracted with 600 microL RLT lysis buffer (Quiagen,
Courtaboeuf, France) following manufacturer's instruc-
tions and quantitated by spectrophotometry analysis. 2.5
µg RNA were reverse transcribed as previously described
[46]. All PCR reactions were carried out using 0.2 mM de-
oxynucleoside, 1 microM of each primer and 0.014 U/mi-
croL of thermostable DNA polymerase (Q-biogene,
Illkirch, France), in a final volume of 25 microL lambda
gt11 inserts corresponding to the positive clones were am-
plified by PCR using specific phage primers and se-
quenced as previously described [29]. Specific primers
were chosen for the clone termed 12 K and the total se-
quence of the coding region was obtained by RACE (Rap-
id Amplification of cDNA Ends)-PCR using high fidelity
PWO polymerase (Boehringer Mannheim) and 5 microL
L. infantum cDNA, as described previously (42). Briefly,
the amplification of the 3' end of 12K cDNA was obtained
with the specific primer F and the oligoT primer contain-
ing SalI site and its 5' end was obtained with the specific
primer R and the "mini-exon" primer [47] with EcoRI site
(underlined) 5'-TAGGGATCCAACTAAGCGTATATAAG
TATCAGTTT-3'. After sequencing of 5' and 3' ends, the
coding region corresponding to the clone 12K was
amplified from L. infantum promastigote and amastigote
cDNAs, using PWO polymerase and two specific primers
F and R containing EcoRI and SalI sites, respectively. The
clone 12K is termed thereafter Lepp12.
Expression and purification of recombinant proteins
PCR amplified coding region of Lepp12 (Lepp12-ORF)
and pGEX-6P-1 vector (Amersham Pharmacia Biotech,
Orsay, France) were digested with an excess of EcoRI and
SalI (Biolabs Ozyme, Saint Quentin, France) restriction
enzymes. The ligation between pGEX-6P-1 and Lepp12-
ORF and the expression of the fusion protein with glutath-
ione S-transferase (GST) in E. coli BL21 were performed as
previously described [29]. The purification of GST-Lepp12
was done essentially as recommended by the supplier
(Bulk GST Purification Module, Pharmacia). Briefly, the
recombinant bacteria were harvested, washed once in
NaCl 0.9% by sedimentation at 2500 g for 15 min at 4°C,
resuspended in 1:20 volume of PBS containing protease
inhibitors (complete protease-inhibitor-cocktail, Roche)
and lysed by two sonication cycles of 10 seconds. After
solubilization with 1% Triton X-100, the fusion protein
GST-Lepp12 was adsorbed to glutathione-Sepharose gel
(50% in PBS) for 30 min. After incubation, in order to ob-
tain material without bacterial contamination, 10 washes
with 10 volumes of PBS were carried out and the fusion
protein was then eluted either using reduced glutathione
20 mM (in Tris-HCl 50 mM buffer pH 8) or with SDS
0.1%. Purified material was analyzed by SDS-PAGE (14%
polyacrylamide gel), after staining with Coomassie G-250
stain (Invitrogen). E. coli BL21 transformed with pGEX-
6P-1 vector without Lepp12-ORF were treated similarly,
and the resulting recombinant GST was purified in paral-
lel. E. coli BL21 not transformed were also treated similar-
ly. For phosphorylation experiments (see below), the
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fusion proteins GST-Lepp12 and GST were used in a form
adsorbed on the glutathione-Sepharose gel and were
maintained in Assay Dilution Buffer (20 mM MOPS, pH
7.2, 25 mM beta-glycerophosphate, 1 mM sodium or-
thovanadate, 1 mM dithiotreitol, 1 mM CaCl2). E. coli
BL21 proteins adsorbed non specifically on glutathione-
Sepharose gel, were used as additional controls.
ELISA
The time course of specific anti-Lepp12 IgG levels in VL
patient sera was determined by a classical enzyme-linked
immunosorbent assay (ELISA) procedure analogous to
that described previously for antileishmanial antibody de-
termination [48]. Briefly, GST-Lepp12, or control GST,
was coated overnight at 1 microg/ml (50 microL), the sera
were tested at 1:100 dilution, and revealed with anti-hu-
man IgG peroxidase-conjugate used at 1:2000 dilution.
Sera from leishmanin skin test (LST) negative subjects
were used controls and resulted in OD values below 0.1.
Incubation steps were performed in 0.1 M phosphate
buffer pH 7.2 containing 1% (wt/vol) skimmed dry milk,
0.12% (vol/vol) Triton X-100, 0.2% (vol/vol) chloroform,
0.02% Thimerosal, 100 microg phenol red/ml.
Production of immunopurified anti-Lepp12 antibody
Anti-Lepp12 antibodies were immunopurified from sera
of VL patients in acute phase of VL on a GST-Lepp12-coat-
ed column. Briefly, 40 microg of GST-Lepp12 were coated
on 200 microL of (2 times PBS-washed) Latex (Styrene di-
vinylbenzene, 90.7 micron, Sigma), by overnight incuba-
tion at 25°C. The Lepp12-coated latex beads were mixed
with 1 ml of sephadex gel G-25 (Pharmacia, France) and
poured into a 2 ml column. The column was extensively
washed with PBS and 0,1 M HCl-Glycine buffer pH 2,6
containing 0.5 M NaCl. VL patient serum (2 ml),
previously absorbed with 0.5 ml of E. coli lysate, was load-
ed into the column. The column was washed in PBS and
bound antibodies were eluted with the HCl-glycine buff-
er. After neutralization with 1 M Tris solution, concentra-
tion against dry PEG 35000 and dialysis with PBS, the
antibody solution was supplemented with 2 mg/ml BSA
filtrated on 0.22 micron millipore membrane and stored
at 4°C. Typically 20 microg of immunopurified antibody
were obtained from 1 ml of serum and was stored at 40
microg/ml concentration.
Western blot analysis
Approximately 5 microg of the recombinant protein
(GST-Lepp12 or GST) purified from a bacterial culture as
described above, or 40 microg of total leishmanial pro-
teins [33], were loaded per well of SDS-14 % polyacryla-
mide gel (mini-protean II cell, ref Bio-Rad) and
electrotransferred to nitrocellulose (minitransblot cell,
Bio-Rad) as previously described [29,33]. Patient and con-
trol (from LST negative subjects) sera were used at 1:50
and 1:100 dilutions and peroxidase-conjugates directed
against human immunoglobulin G (Sigma Illkrich,
France) were used at 1:100 and 1:1000 dilution, respec-
tively. To reveal immunopurified anti-Lepp12 antibody,
prepared as described above and used at 1:8, peroxidase-
conjugates directed against human IgG were used at
1:500. Enzymatic activity was revealed with 1.5 mM di-
aminobenzidine, 0.38 mM CoCl2, 0.03 % H2O2 in PBS.
Alternatively, 120 microg (in 30 microL) of leishmanial
proteins were loaded per well of mini-gel and electro-
transferred to nitrocellulose membrane, as above. After
saturation (10 mM Tris-HCl pH 7.4, 3 % BSA (Sigma, Il-
lkrich, France), 150 mM NaCl, 1 mM EDTA, 0.1 %,
Tween, 0.5 % Gelatine) for 2 h at 4°C, nitrocellulose was
incubated with 0.25 mg/ml of anti-P-Ser/P-Thr antibody
(Cliniscience, Montrouge France) for 18 h at 4°C, washed
3 times (1 % TBS-NP40, 10 min), then saturated again.
Anti-rabbit immunoglobulin (IgG) peroxidase conjugate
(Dako, Trappes, France) was used at 1:10000 dilution (1
h in saturation buffer). Enzymatic activity was revealed
with ECL kit (Enhance Chemiluminescence, Amersham
Pharmacia Biotech, Orsay, France) as recommended by
the supplier on a sensitive photographic MP-hyperfilm
(Amersham, Orsay, France). The quality of the transfert
on nitrocellulose was regularly checked and confirmed by
gel staining with Coomassie G-250 stain (Invitrogen,
Netherland) and nitrocellulose membrane staining with
Amido-Black.
In vitro phosphorylations
Experiments were carried out with recombinant GST-
Lepp12 or immunoprecipitated native Lepp12 and his-
tone mix from bovine calf thymus (Upstate
Biotechnology, Euromedex France, reference number14-
155) as positive control and GST and BL21 lysate as
negative controls, in accordance with the protocol sup-
plied in PKC assay kit (Upstate Biotechnology, Eurome-
dex France). Briefly, different proteins (10 microg) were
incubated for 10 min at 30°C in the presence of 10 micro-
Ci gamma-P32 ATP (ICN) in Assay Dilution Buffer (ADB)
with sonified (90 sec) protein kinase C lipid activator, and
with 25 ng exogenous PKC (Upstate Biotechnology, Eu-
romedex, Mundolsheim, France) or 15 microg of promas-
tigote lysate or THP-1 lysate prepared as described above.
The reaction was stopped by addition of electrophoresis
buffer, and the samples were electrophorezed and electro-
transferred to nitrocellulose membrane. Phosphorylated
material was revealed by autoradiograpy as described
above. Exposition times are indicated in figure legends.
Transfection of recombinant GST-Lepp12 into THP-1 cells
The transfection of the recombinant GST-Lepp12 protein
into THP-1 cells was carried out using Chariot Transfec-
tion Kit (Active Motive, Rixensart, Belgium) following the
manufacturer's instruction manual. Briefly, 3 × 105 cells
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were seed in 3 ml of complete medium per well of a 6-well
plate and cultured in usual conditions. After 48 h of cul-
ture, 200 microL of Chariot-protein complex (see below)
was overlaid on the pellet of twice-washed THP-1 cells,
and 400 microL serum-free medium was added to the
overlay to achieve the final transfection volume of 600
microL. After incubation at 37°C for one hour, 1 ml of
complete growth medium was added to the cells and in-
cubation was allowed to continue for 2 more hours. The
transfected cells were then used for activation experi-
ments. The Chariot-protein complex formation was
achieved by incubation of 100 microL protein dilution (2
microg of protein (GST or GST-Lepp-12) in 100 microL of
PBS) with the 100 microL Chariot dilution (6 microL of
Chariot in 100 microL of sterile water) at room tempera-
ture for 30 minutes.
Cell activation and cytokine assays
In order to assess the potential presence of endotoxin-like
material in GST and GST-Lepp12 preparations selected for
the transfection experiments, THP-1 cells were cultured at
2.5 × 105/ml in the presence of various concentrations of
both proteins for 24 h at 37°C in standard conditions.
Culture wells were extracted with 9 mM CHAPS detergent
and assayed for IL-1beta production by sandwich ELISA as
previously reported [49]. The threshold sensitivity of the
ELISA was 10 pg/ml and the technique was shown to
quantify equally well the mature secreted and the intracel-
lular forms of the cytokine. GST-transfected, GST-Lepp12-
transfected and untransfected THP-1 cells (at 3.75 × 105
cells/ml) were challenged with various concentrations of
phorbol-12-myristate 13-acetate (PMA, 0.1–10 ng/ml) or
LPS (0.1–10 microg/ml) or left unstimulated. Culture
wells were extracted and IL-1beta was quantified as de-
scribed above.
Nucleotide sequence accession number
The Lepp12 cDNA sequence obtained in this study has
been assigned GenBank accession number AF540954.
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